首页> 外文期刊>Nanotechnology >Cancer-targeted and glutathione-responsive micellar carriers for controlled delivery of cabazitaxel
【24h】

Cancer-targeted and glutathione-responsive micellar carriers for controlled delivery of cabazitaxel

机译:癌症靶向和谷胱甘肽响应胶束载体,用于对Cabazitaxel的受控输送

获取原文
获取原文并翻译 | 示例
           

摘要

Novel type of multifunctional polymeric micelles (PMs) designated as HM-PMss/CTX micelles were developed in the present study for tumor-targeted and glutathione (GSH)-responsive delivery of cabazitaxel (CTX). The surface of the vehicles was modified with piloting molecules (HM-3 peptide), which targets alpha(v)beta(3) integrin overexpressed on cancer cells, and the micelle core was cross-linked by GSH-disintegrable disulfide linkages for controlled drug release. HM-PMss/CTX micelles were prepared using a mixture of two functionalized amphiphilic block copolymers and found to physically encapsulate CTX with excellent entrapment efficiency (93.94 +/- 4.19%), drug-loading capacity (8.39 +/- 2.28%), and a narrow size distribution. In vitro release profiles showed that CTX remained stably entrapped in the micelles in a release medium without GSH or with GSH of low concentration, while undergoing a rapid release in a highly reductive environment. Cellular uptake experiments showed that the conjugation of the targeting peptide, containing an arginine-glycine-aspartate sequence, enhanced the cellular uptake of HM-PMss/CTX micelles via alpha(v)beta(3) integrin-mediated endocytosis. In vitro cell viability measurements revealed that blank micelles were biocompatible, while HM-PMss/CTX micelles, owing to their tumor-targeting ability and GSH sensitivity, effectively inhibited the proliferation of MDA-MB-231 breast cancer cells. These results indicate that HM-PMss/CTX micelles could be a promising platform for future intelligent drug delivery in cancer therapy.
机译:作为HM-PMSS / CTX胶束指定为HM-PMS / CTX胶束的新型多官能聚合物胶束(PMS),用于Cabazitaxel(CTX)的肿瘤靶向和谷胱甘肽(GSH) - 夸张的递送。用试点分子(HM-3肽)改性载体的表面,其靶向α(v)β(3)整合蛋白在癌细胞上过表达,胶束核心通过GSH-崩解的二硫键与受控药物交联释放。使用两种官能化两亲嵌段共聚物的混合物制备HM-PMS / CTX胶束,并发现具有优异的夹带效率(93.94 +/- 4.19%),药物负载能力(8.39 +/- 2.28%),以及狭窄的分布。体外释放曲线显示CTX在没有GSH或GSH的释放培养基中稳定地夹在胶束中,或者具有低浓度的GSH,同时在高度还原环境中进行快速释放。蜂窝摄取实验表明,靶向肽的缀合,含有精氨酸 - 甘氨酸 - 天冬氨酸序列,通过α(v)β(3)整联蛋白介导的内吞作用增强了HM-PMS / CTX胶束的细胞吸收。体外细胞活力测量显示,由于其肿瘤靶向能力和GSH敏感性,HM-PMS / CTX胶束的坯料胶束是生物相容的,因此有效地抑制了MDA-MB-231乳腺癌细胞的增殖。这些结果表明,HM-PMS / CTX胶束可能是癌症治疗中未来智能药物递送的有希望的平台。

著录项

  • 来源
    《Nanotechnology》 |2019年第5期|共14页
  • 作者单位

    East China Univ Sci &

    Technol Shanghai Collaborat Innovat Ctr Biomfg Technol State Key Lab Bioreactor Engn Shanghai 200237 Peoples R China;

    East China Univ Sci &

    Technol Sch Mat Sci &

    Engn Key Lab Ultrafine Mat Minist Educ Shanghai 200237 Peoples R China;

    Shandong Univ Tradit Chinese Med Dept Gastroenterol Affiliated Hosp Jinan 250011 Shandong Peoples R China;

    East China Univ Sci &

    Technol Shanghai Collaborat Innovat Ctr Biomfg Technol State Key Lab Bioreactor Engn Shanghai 200237 Peoples R China;

    East China Univ Sci &

    Technol Shanghai Collaborat Innovat Ctr Biomfg Technol State Key Lab Bioreactor Engn Shanghai 200237 Peoples R China;

    East China Univ Sci &

    Technol Sch Pharm State Key Lab Bioreactor Engn Shanghai Key Lab Chem Biol Shanghai 200237 Peoples R China;

    East China Univ Sci &

    Technol Sch Pharm State Key Lab Bioreactor Engn Shanghai Key Lab Chem Biol Shanghai 200237 Peoples R China;

    East China Univ Sci &

    Technol Shanghai Collaborat Innovat Ctr Biomfg Technol State Key Lab Bioreactor Engn Shanghai 200237 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 特种结构材料;
  • 关键词

    GSH-responsive; tumor-targeting peptide; cabazitaxel; polymeric micelles;

    机译:GSH响应;肿瘤靶向肽;Cabazitaxel;聚合物胶束;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号